Aurora Cannabis Inc.
TSX:ACB.TODrug Manufacturers - Specialty & Generic
Healthcare
$6.31 +0.48%
+$0.02 today
- Market cap
- $414.85M
- Beta
- 1.34
- P/E (TTM)
- -3.2
- EPS (TTM)
- -$1.31
52W Low $3.77High $9.33
Volume 0.32M
Average 0.42M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$13.51M
FY 2026 · Annual
Investing Cash Flow
-$73.43M
FY 2026 · Annual
Financing Cash Flow
$9.76M
FY 2026 · Annual
Cash Flow Statement
CAD
Metric | FY2022 Jun 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | (1.72B) | (265.33M) | (59.05M) | 15.76M | (58.62M) |
| Depreciation & Amortization | 93.66M | 43.57M | 33.07M | 22.55M | 14.19M |
| Deferred Income Tax | (2.19M) | (18.4M) | (1.67M) | (3.19M) | 55K |
| Stock-Based Compensation | 13.76M | 16.89M | 12.72M | 11.52M | 7.29M |
| Change in Working Capital | 52.65M | (25.12M) | (15.63M) | 10.21M | (9.21M) |
| Accounts Receivables | 18.34M | 5.53M | (4.33M) | 5.24M | (8.15M) |
| Inventory | 21.07M | 49.03M | 3.62M | (15.05M) | 7.44M |
| Accounts Payables | 6.77M | (8.06M) | (15.7M) | 14.91M | (8.04M) |
| Other Working Capital | 6.48M | (71.61M) | 790K | 5.11M | (9.21M) |
| Other Non-Cash Items | 1.45B | 190.11M | (37.96M) | (40.85M) | 54.32M |
| Operating Cash Flow | (110.27M) | (115.82M) | (68.51M) | 16.01M | (13.51M) |
| Capital Expenditures | (32.21M) | (12.13M) | (16.96M) | (18.86M) | (22.55M) |
| Acquisitions (Net) | (23.42M) | (18.54M) | (5.55M) | 0 | 1.1M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 3.36M | 4.99M | 5.49M | 0 |
| Other Investing Activities | 19.46M | 16K | 12.02M | (956K) | (51.98M) |
| Investing Cash Flow | (36.17M) | (27.29M) | (5.49M) | (14.33M) | (73.43M) |
| Debt Repayment | (170.83M) | — | (85.76M) | (805K) | (5.02M) |
| Common Stock Issued | 350.19M | 73.19M | 37.93M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (31.58M) | (95.21M) | (89K) | 689K | (154K) |
| Financing Cash Flow | 147.78M | (56.48M) | (47.92M) | (116K) | 9.76M |
| Effect of Forex Changes | 15.01M | 15.54M | 297K | 264K | 4.33M |
| Net Change in Cash | 16.35M | (140.01M) | (121.5M) | 1.83M | (72.85M) |
| Free Cash Flow | (142.48M) | (127.95M) | (85.46M) | (2.85M) | (36.06M) |
Free Cash Flow
Net Income to FCF bridge
FY2026
= Net Income-$58.6M
+ D&A$14.2M
+ Stock-Based Comp$7.3M
+ Deferred Tax$55.0K
- Working Capital-$9.2M
+ Other Non-Cash$54.3M
= Operating Cash Flow-$13.5M
- Capex-$22.5M
= Free Cash Flow-$36.1M
Analysis
FY2026 free cash flow is -$36.1M. FCF conversion is 61.5% of net income. Operating cash flow was -$13.5M, with capex of -$22.5M. The largest bridge item is Other Non-Cash at $54.3M.
Recent Filings
Recent regulatory filings
No filings found.
Does ACB.TO generate free cash flow?
Aurora Cannabis Inc. (ACB.TO) generated -$36.06M of free cash flow in fiscal 2026.
How much operating cash flow does ACB.TO produce?
Operating cash flow was -$13.51M, before capital expenditures of $22.55M.
Continue the stock analysis
Jump to another research area for this company.